Carvedilol Tablet, Film Coated
Product Images NDC 43063-125

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 43063-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063125)

Description: This is a medication label for Carvedilol tablets containing 12.5 MG strength. The label has information about the quantity of tablets, reorder number, lot number, expiration date, and contact information for medical advice and reporting side effects. The label also indicates that abrupt stopping of medication requires physician consultation. There are instructions on dosage and the organoleptic markings for the tablet, along with a Barcode and lot number. However, some parts of the text are not readable due to errors.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

This is a data table showing the effects of various subgroups on mortality for COPERNICUS study. The subgroups include gender, age, ethnicity, diabetic status, ischemic status, heart rate, blood pressure, and use of spironolactone. The hazard ratio is also shown. No further information is available.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

FDA Label Image

Chemical Structure (Carvedilol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.